Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

6.74USD
24 May 2019
Change (% chg)

$0.21 (+3.22%)
Prev Close
$6.53
Open
$6.57
Day's High
$6.77
Day's Low
$6.56
Volume
97,289
Avg. Vol
141,442
52-wk High
$7.84
52-wk Low
$5.07

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 0.05 0.10 0.03 0.03
Quarter Ending Sep-19 4 0.05 0.10 0.03 0.03
Year Ending Dec-19 4 0.16 0.30 0.12 2.28
Year Ending Dec-20 3 25.14 75.12 0.11 28.09
Earnings (per share)
Quarter Ending Jun-19 4 -0.17 -0.16 -0.18 -0.23
Quarter Ending Sep-19 4 -0.18 -0.16 -0.20 -0.24
Year Ending Dec-19 5 -0.69 -0.64 -0.75 -0.65
Year Ending Dec-20 4 -0.32 0.07 -0.53 -0.09
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 93.20 35.48
P/E High - Last 5 Yrs. -- 165.14 57.43
P/E Low - Last 5 Yrs. -- 51.92 28.10
Beta -- 1.21 0.95
Price to Sales (TTM) -- 40.13 9.28
Price to Book (MRQ) -- 11.48 4.15
Price to Tangible Book (MRQ) -- 16.72 4.94
Price to Cash Flow (TTM) -- 61.14 24.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.68
Dividend Yield - 5 Year Avg -- 0.06 1.30
Dividend 5 Year Growth Rate -- 0.94 6.71
Payout Ratio(TTM) -- 1.56 35.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 59.08 16.40
Sales (TTM) vs TTM 1 Yr. Ago -- 46.19 8.26
Sales - 5 Yr. Growth Rate -- 32.98 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -9.33 19.71
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 22.17 7.23
Capital Spending - 5 Yr. Growth Rate -- 24.87 8.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.43
Current Ratio (MRQ) -- 3.84 3.36
LT Debt to Equity (MRQ) -- 7.71 14.37
Total Debt to Equity (MRQ) -- 20.81 19.78
Interest Coverage (TTM) -- 32.37 13.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.42 50.23
Gross Margin - 5 Yr. Avg. -- 59.23 51.31
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -16.11 15.84
Operating Margin (TTM) -- -116.39 -4.60
Operating Margin - 5 Yr. Avg. -- -31.95 11.09
Pre-Tax Margin (TTM) -- -116.40 -4.95
Pre-Tax Margin - 5 Yr. Avg. -- -34.49 15.89
Net Profit Margin (TTM) -- -121.99 -8.72
Net Profit Margin - 5 Yr. Avg. -- -39.40 11.14
Effective Tax Rate (TTM) -- 17.16 19.94
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 8,861,170 746,541,307
Net Income/Employee (TTM) -- 1,554,572 87,192,468
Receivable Turnover (TTM) -- 11.38 5.67
Inventory Turnover (TTM) -- 2.45 3.66
Asset Turnover (TTM) -- 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.13 9.44
Return on Assets - 5 Yr. Avg. -- 6.07 10.47
Return on Investment (TTM) -- 7.47 11.75
Return on Investment - 5 Yr. Avg. -- 7.95 13.33
Return on Equity (TTM) -- 7.94 16.52
Return on Equity - 5 Yr. Avg. -- 9.00 14.90

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.